Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial
Jun Li, Jingliang Xing, Yefa Yang, Jingfeng Liu, Wentao Wang, Yong Xia, Zhenlin Yan, Kui Wang, Dong Wu, Lu Wu, Xuying Wan, Tian Yang, Chunfang Gao, Anfeng Si, Hongyang Wang, Mengchao Wu, Wan Yee Lau, Zhi‐Nan Chen, Feng Shen
Topics & Concepts
MedicineHepatocellular carcinomaAdjuvantInternal medicinePopulationHepatectomyIntention-to-treat analysisGastroenterologyRandomized controlled trialSurgeryResectionEnvironmental healthHepatocellular Carcinoma Treatment and PrognosisAmoebic Infections and TreatmentsCancer, Hypoxia, and Metabolism